My name is Mark Herndon, Chief Financial Officer of Horizon Kinetics. We're pleased to have you join us for our call that will cover our results for the fourth quarter and full year of 2025. But first ...
By any measure, 2025 was a landmark year for Cibus, Inc., not because of any single headline, but because of a convergence of key themes that are shaping the trajectory of the gene editing industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results